U.S. market Closed. Opens in 21 hours 2 minutes

EIGR | Eiger BioPharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-06-30
Revenue15.77M13.48M12.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue24.00K1.84M745.00K645.00K486.00K54.00K41.00K23.00K11.00KN/AN/AN/AN/A
Gross Profit15.75M11.65M11.40M-645.00K-486.00K-54.00K-41.00K-23.00K-11.00KN/AN/AN/AN/A
Operating Expenses87.53M104.39M88.34M62.15M68.90M51.05M41.52M46.12M34.39M33.02M19.96M15.95M6.03M
Selling, General & Admin25.20M29.11M23.90M20.56M17.11M13.96M12.00M13.11M12.44M10.34M3.04M2.63M1.83M
Research & Development62.33M75.28M64.44M41.59M51.79M37.09M29.52M33.01M21.96M22.68M16.93M13.31M4.19M
Other Operating Expenses87.00K-963.00K46.49M-12.00K-15.00K-12.00K186.00K-277.00K5.00K-835.00K25.00K147.00K152.00K
Operating Income-71.79M-92.74M-76.94M-62.15M-68.90M-51.05M-41.52M-46.12M-42.18M-33.02M-19.96M-15.95M-6.03M
Other Expenses / Income-3.17M-4.01M43.09M-2.90M-1.35M-1.34M-928.00K-967.00K-2.23M-835.00K-127.00K74.00K-965.00K
Before Tax Income-74.96M-96.75M-33.85M-65.05M-70.25M-52.39M-42.45M-47.09M-44.41M-33.85M-20.09M-15.87M-6.99M
Income Tax Expenses6.00K23.00K64.00K3.58M3.39M985.00K1.67M390.00K2.31M-153.00K-12.00K101.00K1.28M
Net Income-74.96M-96.78M-33.92M-68.63M-73.64M-52.39M-42.45M-47.09M-44.41M-33.85M-20.00M-15.72M-6.99M
Interest Expenses5.47M4.13M3.56M3.59M3.41M2.33M1.52M690.00K2.30M741.00K59.00K108.00K1.12M
Basic Shares Outstanding1.48M1.39M34.63M29.88M24.43M13.63M8.73M8.36M1.27M1.57M802.36K802.36K802.36K
Diluted Shares Outstanding1.48M1.39M34.63M29.88M24.50M13.63M8.73M8.36M1.27M1.57M802.36K802.36K802.36K
EBITDA-68.74M-92.62M-76.94M-60.81M-66.36M-50.06M-40.92M-46.40M-33.82M-33.02M-19.80M-15.70M-5.79M
EBITDA Margin-435.81%-686.90%-633.66%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-69.49M-92.62M-30.29M-61.46M-66.85M-49.08M-39.26M-46.01M-39.80M-33.27M-19.95M-15.51M-4.59M
EBIT Margin-440.57%-686.90%-249.50%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙